These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6145580)

  • 1. [Controlled study of the disinhibiting effect of low doses of sulpiride in severe schizophrenic psychoses].
    Petit M; Zann M; Colonna L
    Encephale; 1984; 10(1):25-8. PubMed ID: 6145580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):189-201. PubMed ID: 234359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

  • 4. Dosage finding and outcome in the treatment of schizophrenic inpatients with amisulpride. Results of a drug utilization observation study.
    Linden M; Scheel T; Xaver Eich F
    Hum Psychopharmacol; 2004 Mar; 19(2):111-9. PubMed ID: 14994321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies of sulpride on long standing hospitalized schizophrenic patients].
    Eckmann F
    Arzneimittelforschung; 1974 Jul; 24(7):993-4. PubMed ID: 4603403
    [No Abstract]   [Full Text] [Related]  

  • 6. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
    Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
    Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ
    Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method].
    Asada S; Ishimaru T; Kubo S; Kodama H; Masuda K
    Encephale; 1976; 2(1):73-83. PubMed ID: 770152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low vs. high doses of levosulpiride on negative symptoms of schizophrenia.
    Catapano F; Maj M; Grimaldi F; Ventra C; Kemali D
    Pharmacopsychiatry; 1992 May; 25(3):166. PubMed ID: 1635937
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
    J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of inadequate lactation with oral sulpiride and buccal oxytocin.
    Ylikorkala O; Kauppila A; Kivinen S; Viinikka L
    Obstet Gynecol; 1984 Jan; 63(1):57-60. PubMed ID: 6361642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of sulpiride in chronic schizophrenic patients.
    Edwards JG; Alexander JR; Alexander MS; Gordon A; Zutchi T
    Br J Psychiatry; 1980 Dec; 137():522-9. PubMed ID: 7011469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1985; 85(1):8-13. PubMed ID: 3920702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical-neuroleptic investigation of N-((1-ethyl-pyrrolidine-2-yl)-methyl)-2-methoxy-5-sulfamyl-benzamide-neuroleptic sulpiride (Dogmatil) in acutly ill schizophrenics].
    Haase HJ; Floru L; Ulrich F
    Int Pharmacopsychiatry; 1974; 9(2):77-94. PubMed ID: 4603413
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
    Kreinin A; Epshtein S; Sheinkman A; Tell E
    Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
    Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.